Justin W Yorke is of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 75,729 shares of PCSA, which is worth approximately $87,845. The most recent transaction as insider was on Oct 12, 2023, when has been sold 6,000 shares (Common Stock) at a price of $0.3 per share, resulting in proceeds of $1,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.7K
0% 3M change
0% 12M change
Total Value Held $87,845

Justin W Yorke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2023
BUY
Grant, award, or other acquisition
$1,800 $0.3 p/Share
6,000 Added 7.34%
75,729 Common Stock
Oct 10 2023
BUY
Grant, award, or other acquisition
$2,520 $0.21 p/Share
12,000 Added 14.68%
69,729 Common Stock
Jun 27 2023
BUY
Exercise of conversion of derivative security
-
23,636 Added 29.41%
56,729 Common Stock
Dec 31 2022
BUY
Grant, award, or other acquisition
-
18,208 Added 35.49%
33,093 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
4,393 Added 24.26%
13,716 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
4,393 Added 24.26%
13,716 Common Stock
Aug 05 2021
BUY
Grant, award, or other acquisition
-
1,169 Added 0.39%
301,875 Common Stock

Also insider at

SBEV
SPLASH BEVERAGE GROUP, INC. Consumer Defensive
JWY

Justin W Yorke

Hanover, MD

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA